FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to producing drug preparations, namely represents a process of producing microcapsules of the antiseptic Dorogov's stimulator (ADS fraction 2). The process of microencapsulation represents a method of a non-solvent addition; a microcapsule coating is kappa-carageenan, while a core is the ADS fraction 2.
EFFECT: implementing the invention provides simplifying and accelerating the process of microencapsulation, reduces the microencapsulation loss (higher weight yield).
1 dwg, 2 ex
Authors
Dates
2015-03-10—Published
2013-06-04—Filed